Frontiers in Cellular and Infection Microbiology (Nov 2022)

The lncRNAs involved in regulating the RIG-I signaling pathway

  • Jing Liu,
  • Qinglu Ji,
  • Feng Cheng,
  • Dengwang Chen,
  • Tingting Geng,
  • Yueyue Huang,
  • Jidong Zhang,
  • Jidong Zhang,
  • Jidong Zhang,
  • Yuqi He,
  • Tao Song,
  • Tao Song,
  • Tao Song

DOI
https://doi.org/10.3389/fcimb.2022.1041682
Journal volume & issue
Vol. 12

Abstract

Read online

Understanding the targets and interactions of long non-coding RNAs (lncRNAs) related to the retinoic acid-inducible gene-I (RIG-I) signaling pathway is essential for developing interventions, which would enable directing the host inflammatory response regulation toward protective immunity. In the RIG-I signaling pathway, lncRNAs are involved in the important processes of ubiquitination, phosphorylation, and glycolysis, thus promoting the transport of the interferon regulatory factors 3 and 7 (IRF3 and IRF7) and the nuclear factor kappa B (NF-κB) into the nucleus, and activating recruitment of type I interferons (IFN-I) and inflammatory factors to the antiviral action site. In addition, the RIG-I signaling pathway has recently been reported to contain the targets of coronavirus disease-19 (COVID-19)-related lncRNAs. The molecules in the RIG-I signaling pathway are directly regulated by the lncRNA–microRNAs (miRNAs)–messenger RNA (mRNA) axis. Therefore, targeting this axis has become a novel strategy for the diagnosis and treatment of cancer. In this paper, the studies on the regulation of the RIG-I signaling pathway by lncRNAs during viral infections and cancer are comprehensively analyzed. The aim is to provide a solid foundation of information for conducting further detailed studies on lncRNAs and RIG-I in the future and also contribute to clinical drug development.

Keywords